PAtients With Symptomatic Peripheral Artery Disease on Rivaroxaban-acetylsalicylic Acid Combination Therapy (PRO-PAS)
Clinical trial NCT06239415 · UNKNOWN
Trial details
- NCT number
- NCT06239415
- Sponsor
- Istituti Clinici Scientifici Maugeri SpA
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-03-31
- Primary completion
- 2024-03-31
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.